Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002963 · ClinicalTrials.gov registry record · Phase 2
Photodynamic Therapy in Treating Patients With Skin Cancer
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002963: Completed Phase 2 study, sponsored by Roswell Park Cancer Institute.
NCT00002963 is a Phase 2 study that has completed, run by Roswell Park Cancer Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002963, a Phase 2 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in treating patients with skin cancer.
Interventions
- PROCEDURE conventional surgery
- DRUG aminolevulinic acid hydrochloride
Trial Details
| Field | Value |
|---|---|
| Start Date | 1993-11 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
What the finished NCT00002963 record still lists
NCT00002963 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00002963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002963 about?
NCT00002963 is a clinical study titled "Photodynamic Therapy in Treating Patients With Skin Cancer". RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodyn...
What is the current status of trial NCT00002963?
This trial is currently completed. It is a Phase 2 study. The study started on 1993-11. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00002963?
The interventions under investigation include: conventional surgery (PROCEDURE), aminolevulinic acid hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002963?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia